Underwriter (Number Of Offerings As Lead Underwriter)

After-Market Performance (Average)**

Deutsche Banc Alex. Brown (1)

+96%

CIBC Oppenheimer Corp. (1)

+90%

BancBoston Robertson Stephens (1)

+89%

Donaldson, Lufkin & Jenrette (1)

+85%

First Marathon Securities Inc. (1)

+80%

Westport Resources Investment Services Inc. (1)

+70%

ING Baring Furman Selz LLC (2)

+68%

Credit Suisse First Boston Corp. (1)

+54%

Hambrecht & Quist LLC# (1)

+41%

Prudential Vector Securities (1)

+40%

Morgan Stanley & Co. (1)

+34%

J.P. Morgan & Co. (2)

+27%

Cruttendon Roth Inc. (1)

+24%

U.S. Bancorp Piper Jaffray (1)

+23%

Robert Fleming & Co. Ltd. (1)

+17%

TD Securities Inc. (1)

+14%

Levesque Beaubien Geoffrion Inc. (1)

-53%

Notes:

These charts are updated from those that appeared Aug. 30 to reflect the addition of United Therapeutics Corp's $62.1 million initial public offering in June. Deutsche Banc Alex. Brown was the lead underwriter. A.G. Edwards & Sons Inc and Prudential Vector Securities were co-managers

*The offerings in this chart include only those that were completed on U.S. stock exchanges (NASDAQ, NYSE, or AMEX), the Canadian Stock Exchange (TSE) and the London Stock Exchange (LSE) from January-July 1999. Gross proceeds exclude additional funding raised from the excercise of overallotment options

**After-market performance is expressed as the percent change in stock price between the IPO price and the closing price on 8/25/99. For underwriters with multiple offerings, the after-market performance (as a percent change) was calculated for each stock in that underwriter's "group", the percentage summed, and then averaged.

# Hambrecht & Quist LLC acted as placement agent for Ribozyme Pharmaceutical Inc.'s 7/99 follow-on offering